News

from the fight to #SaveIndiePharmacy

New York Times’ The Middlemen series

Featured
Giant Companies Took Secret Payments to Allow Free Flow of Opioids
Giant Companies Took Secret Payments to Allow Free Flow of Opioids

Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.

Read more →
Bipartisan Lawmakers Seek to Break Up Giant Health Care Conglomerates
Bipartisan Lawmakers Seek to Break Up Giant Health Care Conglomerates
Read more →
The Powerful Companies Driving Local Drugstores Out of Business
The Powerful Companies Driving Local Drugstores Out of Business

The biggest Pharmacy Benefit Managers (PBMs) are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.

The third in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs .

Read more →
What to Do if You’re Overpaying for Prescriptions
What to Do if You’re Overpaying for Prescriptions

Here’s what to know about your pharmacy benefit manager and how to find out if you are being overcharged for medications.

The first in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs.

Read more →
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
The Opaque Industry Secretly Inflating Prices for Prescription Drugs

Pharmacy Benefit Managers (PBMs) are driving up drug costs for millions of people, employers and the government.

The second in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs.

Read more →
Chairman Comer Calls on PBM Executives to Correct Hearing Testimony
U.S. House of Representatives - Committee on Oversight and Accountability St. Paul Corner Drug (SPCD) U.S. House of Representatives - Committee on Oversight and Accountability St. Paul Corner Drug (SPCD)

Chairman Comer Calls on PBM Executives to Correct Hearing Testimony

At the House Oversight Committee’s hearing, the PBM chief executives made statements that contradict the Committee’s and the Federal Trade Commission’s findings about the PBMs’ self-benefitting practices that jeopardize patient care, undermine local pharmacies, and raise prescription drug prices. The chief executives for CVS Caremark, Express Scripts, and Optum Rx claimed they do not steer patients to PBM-owned pharmacies. The executives also made claims contradicting the Committee’s and FTC’s findings regarding contract negotiations, contract opt outs, and payments to pharmacies.

Read More
Comer: Pharmacy Benefit Managers Must be Held Accountable for Role in Rising Drug Prices
U.S. House of Representatives - Committee on Oversight and Accountability St. Paul Corner Drug (SPCD) U.S. House of Representatives - Committee on Oversight and Accountability St. Paul Corner Drug (SPCD)

Comer: Pharmacy Benefit Managers Must be Held Accountable for Role in Rising Drug Prices

Today, House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) delivered opening remarks at a full committee hearing titled “The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability.” In his opening statement, Chairman Comer detailed how the House Oversight Committee has obtained over 140,000 pages of documents and communications exposing Pharmacy Benefit Managers’ (PBMs) anticompetitive policies and their role in rising drug prices.

Read More